Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
---|
06/28/2001 | WO2000072855A3 Dietary or pharmaceutical composition for use for the prevention or treatment of hyperoxaluria |
06/28/2001 | WO2000070047A3 Full-length molecules expressed in human tissues |
06/28/2001 | WO2000066731A3 Recombinant laminin 5 |
06/28/2001 | WO2000061753A3 Compositions and methods for the treatment and diagnosis of breast cancer |
06/28/2001 | WO2000061180A3 Products and methods for treating ptp lar related diseases |
06/28/2001 | WO2000055194A3 Tuberculosis antigens and methods of use therefor |
06/28/2001 | WO2000003072A9 Method and apparatus for copper plating using electroless plating and electroplating |
06/28/2001 | US20010005592 Chondrocyte-like cells useful for tissue engineering and methods |
06/28/2001 | US20010005591 Production of megakaryocytes by the use of human mesenchymal stem cells |
06/28/2001 | US20010005579 Providing an amount of beta-alanine and L-histidine to blood or blood plasma effective to increase beta-alanylhistidine dipeptide synthesis in a tissue, exposing tissue to blood or plasma to increase accumulation of dipeptide in the tissue |
06/28/2001 | US20010005578 Contacting a sample in a flowable liquid state with a solid substrate comprised of a prion complexing agent and allowing the sample to remain in contact with substrate for time such that prions in the sample bind to the substrate |
06/28/2001 | US20010005505 Destruction of the epithelium of an exocrine gland in the prophylactic and therapeutic treatment of cancer |
06/28/2001 | DE19963104A1 Composition containing a subject's own bacteria, useful for treating conditions associated with deficiency of bacteria, particularly lactobacilli, such as vaginitis |
06/28/2001 | DE19962583A1 New antibodies specific for plasma cells, useful for treatment and diagnosis of autoimmune diseases and plasma cell tumors |
06/28/2001 | DE19958693A1 Verfahren und Zusammensetzungen zur Herstellung von Zelltransplantaten Methods and compositions for the production of cell transplants |
06/28/2001 | DE19957065A1 Screening-Verfahren für Arzneistoffe A screening method for drugs |
06/28/2001 | CA2395578A1 Replication incompetent herpes virus vectors |
06/28/2001 | CA2395576A1 Replication incompetent herpes viruses for use in gene therapy |
06/28/2001 | CA2395136A1 Angiogenesis and vascular permeability modulators and inhibitors |
06/28/2001 | CA2395125A1 A method of treating infectious diseases |
06/28/2001 | CA2394802A1 Somnogenic activity of non-pathogenic lactic acid bacteria |
06/28/2001 | CA2394797A1 Process for producing virus-free plasma protein composition by porous membrane treatment, virus-free plasma protein composition and method of removing viruses |
06/28/2001 | CA2394520A1 Sensitive substance encapsulation |
06/28/2001 | CA2393646A1 Survivin promotion of angiogenesis |
06/28/2001 | CA2393500A1 Methods and compositions for detecting hepatitis e virus |
06/28/2001 | CA2392787A1 Nk cell receptor polynucleotides, polypeptides, and antibodies |
06/27/2001 | EP1110555A1 Antiadhesive agent for the pathogen flora of the skin |
06/27/2001 | EP1110548A1 Substances having antiobese and visceral fat-reducing functions and utilization thereof |
06/27/2001 | EP1109925A1 Recombinant adenovirus for tissue specific expression in heart |
06/27/2001 | EP1109921A1 Fusion receptors specific for prostate-specific membrane antigen and uses thereof |
06/27/2001 | EP1109906A1 Methods and compositions for modulating the interaction between the apj receptor and the hiv virus |
06/27/2001 | EP1109896A1 Adenovirus formulations for gene therapy |
06/27/2001 | EP1109888A1 Enhanced submucosal tissue graft constructs |
06/27/2001 | EP1109887A1 Production and use of dopaminergic cells to treat dopaminergic deficiencies |
06/27/2001 | EP1109818A1 Phosphoepoxides, method for making same and uses |
06/27/2001 | EP1109817A1 Phosphohalohydrins, method for making same and uses |
06/27/2001 | EP1109582A1 Methods to enhance and confine expression of genes |
06/27/2001 | EP1109564A1 Method for removal of hiv and other viruses from blood |
06/27/2001 | EP1109539A1 Nanogel networks and biological agent composition thereof |
06/27/2001 | EP1109462A1 Method for obtaining avian biological products |
06/27/2001 | EP1109447A2 Prolonged storage of red blood cells |
06/27/2001 | EP0831896B1 In ovo vaccination against coccidiosis |
06/27/2001 | CN1301311A Detection of DNA, RNA and proteins |
06/27/2001 | CN1301298A Methods for prevention and treatment of cancer |
06/27/2001 | CN1301181A Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
06/27/2001 | CN1301179A Hemoglobin-polysaccharide conjugates |
06/27/2001 | CN1301174A Method of inducing an anti-tumor response against a lung metastasis in a melanoma patient |
06/27/2001 | CN1301169A Adenovirus-chemotherapeutic combination for treating cancer |
06/27/2001 | CN1301166A Steroidal saponins for treating alzheimer's disease |
06/27/2001 | CN1300628A Colloidal perfusate containing cells for peritoneal dialysis |
06/27/2001 | CN1300620A Process for preparing snuff to treat hepatitis B |
06/27/2001 | CN1300619A Process for preparing snuff to treat hepatitis A |
06/27/2001 | CN1300614A Medicine for treating trigeminal neuralgia |
06/27/2001 | CN1300613A Process for preparing 'Weilinsan' |
06/27/2001 | CN1300610A Medical capsule for treating rheumatism |
06/27/2001 | CN1300608A Medicine-egg mixture for treating hepatitis B |
06/27/2001 | CN1300604A Compound forest frog fat medicine for improving immune function and it spreparing process |
06/27/2001 | CN1300589A Process for preparing dried powder of active lactobacillus |
06/27/2001 | CN1067722C Adenoviral vectors |
06/27/2001 | CN1067585C Mongolian medicine prescription for treating skin disease and preparation method thereof |
06/27/2001 | CN1067579C Medicine for curing tumor and its preparation method |
06/27/2001 | CN1067576C Medicine for burn and scald |
06/27/2001 | CN1067573C Shexingkeyu capsule for curing cardiovascular and cerebrovascular disease and preparing process thereof |
06/27/2001 | CN1067572C Sprayed powder for treating macerative erosive beriberi |
06/27/2001 | CN1067571C Chinese medicine capsule for treating lumbar and cervical protrusion |
06/27/2001 | CN1067569C Zhixuening-medicine for stopping bleeding |
06/27/2001 | CN1067567C Chinese traditional medicine for treating epilepsy |
06/27/2001 | CN1067556C Pills for stimulating |
06/27/2001 | CN1067555C Application of medicinal composition containing termite population and main nest bacterial nursery |
06/27/2001 | CN1067554C Protein mixture and its preparing method |
06/27/2001 | CN1067553C Oyster extract and method for preparing its prepn. |
06/27/2001 | CN1067552C Method for extracting lipid anti-cancer medicine |
06/27/2001 | CN1067551C Preparation of high-immunity pig-sourced serum resisting main infectious diseases of chicken |
06/26/2001 | US6253104 Method of preparing pharmaceutical Moxa extract and apparatus for electrical moxibustion using the same extract |
06/26/2001 | US6252133 Regenerating embryo of mammal; transfer nucleus of diploid cell into oocyte, activate and develop embryo |
06/26/2001 | US6252043 Fusion protein for the treatment of inflammation; for the detection and prevention of leukocyte adhesion to endothelial cells |
06/26/2001 | US6251957 Preventing neutralizing antibodies; gene therapy |
06/26/2001 | US6251867 Antiangiogenic peptides and methods for inhibiting angiogenesis |
06/26/2001 | US6251669 Mammalian, non-tumor derived cells which divide, express neuron-specific markers, and give rise to progeny which differentiate into neuronal cells; for transplantation in treatment of alzheimer's/parkinson's diseases |
06/26/2001 | US6251644 Method for inactivating non-enveloped viral contaminants with a photosensitizer by increasing viral permeability to the photosensitizer |
06/26/2001 | US6251640 Genetically engineered virus having tata element promoter, tet operator sequence, and a gene which inhibits replication of virus when expressed; gene therapy; vaccines; viricides |
06/26/2001 | US6251627 Antigen presenting system and methods for activation of T-cells |
06/26/2001 | US6251580 Platelet storage nutrient solution; for use in the purification of platelets |
06/26/2001 | US6251478 Sensitive substance encapsulation |
06/26/2001 | US6251438 Method of preparing active substances from nacre, products obtained which can be used in particular as medicaments |
06/26/2001 | US6251385 Antigen stimulated cells for cancer treatment, free of bodily fluids |
06/26/2001 | US6251380 Extraction of plants with methanol, dichloromethane, ethyl acetate, mixing and drying then dilution |
06/26/2001 | US6251284 Systems and methods which obtain a uniform targeted volume of concentrated red blood cells in diverse donor populations |
06/21/2001 | WO2001044472A1 Tnfr/opg-like molecules and uses thereof |
06/21/2001 | WO2001044458A2 Bovine immunodeficiency virus (biv) based vectors |
06/21/2001 | WO2001044282A2 Bcl-g polypeptides, encoding nucleic acids and methods of use |
06/21/2001 | WO2001043787A2 A process for preparing an autologous platelet gel and membrane thereof |
06/21/2001 | WO2001043770A2 Method for enhancing immune responses in mammals |
06/21/2001 | WO2001043761A2 Methods for treating and preventing damage to mucosal tissue |
06/21/2001 | WO2001043756A2 Regenerative adjuvant |
06/21/2001 | WO2001043755A2 Regenerative adjuvant (3-way tap) |
06/21/2001 | WO2001043754A2 Pharmaceutical composition comprised of spider venoms, the production thereof, and its use for treating tumor diseases |
06/21/2001 | WO2001043753A2 Combination of ginseng and ginkgo to improve cognitive skills |
06/21/2001 | WO2001043704A1 A skin care composition that mediates cell to cell communication |
06/21/2001 | WO2001043694A2 Compositions and methods for caspase-induced apoptosis |